STOCK TITAN

Celanese (NYSE: CE) CEO & President adds 3,800 shares in open market buy

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Celanese Corp’s CEO and President, who also serves as a director, increased his personal stake in the company through a recent stock purchase. On 12/10/2025, he acquired 3,800 shares of Celanese common stock in an open market transaction coded as a purchase at a price of $41.5899 per share. Following this transaction, he beneficially owned 70,448.703 shares directly and an additional 597.0315 shares indirectly through a 401(k) plan. The form was filed for one reporting person, reflecting continued alignment of the senior executive’s holdings with Celanese’s equity.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Richardson Scott A

(Last) (First) (Middle)
C/O CELANESE CORPORATION
222 W LAS COLINAS BLVD., SUITE 900N

(Street)
IRVING TX 75039

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO & President
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/10/2025 P 3,800 A $41.5899 70,448.703 D
Common Stock 597.0315 I by 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Adam R. Santosuosso, Attorney-in-Fact for Scott A. Richardson 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese Corp (CE) report?

Celanese reported that its CEO and President, who is also a director, purchased 3,800 shares of common stock on 12/10/2025 in an open market transaction.

At what price did the Celanese (CE) insider buy shares?

The senior executive bought 3,800 Celanese common shares at a price of $41.5899 per share.

How many Celanese (CE) shares does the insider own after this transaction?

After the purchase, the reporting person beneficially owned 70,448.703 shares directly and 597.0315 shares indirectly through a 401(k) plan.

What is the role of the reporting person at Celanese Corp (CE)?

The reporting person is listed as both a Director and an Officer, serving as CEO & President of Celanese Corp.

Was this Celanese (CE) insider Form 4 filed for multiple people?

No. The report indicates it is a Form filed by one reporting person, covering the CEO and President’s holdings.

Does the Celanese (CE) insider hold any derivative securities in this report?

The section for derivative securities is included but does not list any derivative transactions or holdings in this report.

Celanese Corp Del

NYSE:CE

CE Rankings

CE Latest News

CE Latest SEC Filings

CE Stock Data

4.68B
109.00M
0.43%
107.35%
6.16%
Chemicals
Plastic Material, Synth Resin/rubber, Cellulos (no Glass)
Link
United States
IRVING